Status:
COMPLETED
Clinical Improvement and in Quality of Life-Functional Dyspepsia-
Lead Sponsor:
Hospital Galdakao-Usansolo
Conditions:
Psychogenic Dyspepsia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Functional dyspepsia (FD)is defined as the presence of symptoms thought to originate in the gastroduodenal region with no evidence of structural disease that is likely to explain the symptoms. The cau...
Detailed Description
Patients were recruited from the digestive services of Galdakao-Usansolo and Basurto hospitals. They were randomly allocated to the control or experimental group. 82 patients were included in the cont...
Eligibility Criteria
Inclusion
- to have chronic upper abdominal symptoms consistent with ROME III criteria for functional dyspepsia
- to have an endoscopy to exclude structural organic causes at the time of the recruitment
Exclusion
- to have any organic pathology that could explain the dyspeptic symptoms
- to be using non-steroidal anti-inflammatory drugs (NSAIDs)
- to suffer physical or psychological impairments preventing them from properly completing the questionnaires
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT01802710
Start Date
March 1 2009
End Date
December 1 2012
Last Update
June 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Galdakao-Usansolo Hospital
Usansolo, Bizkaia, Spain, 48960